NCT05190796 is a clinical trial of platelet indices in Abortion, Recurrent, sponsored by Menoufia University.

Who is sponsoring NCT05190796?

NCT05190796 is sponsored by Menoufia University.

What drugs are being tested in NCT05190796?

Interventions in NCT05190796: platelet indices.

What condition does NCT05190796 study?

NCT05190796 studies Abortion, Recurrent.

Is NCT05190796 still recruiting?

NCT05190796 is currently completed. Last updated 13 January 2022.

Last reviewed 2022-01-13 · How we verify

NCT05190796

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Platelet Indices and Recurrent Pregnancy Loss

Completed Last updated 13 January 2022

What this trial tests

trial testing platelet indices in Abortion, Recurrent in 150 participants. Completed in 1 November 2021.

Timeline

1 September 2020

Primary endpoint
1 September 2021

1 November 2021

Quick facts

Lead sponsor	Menoufia University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	150
Start date	1 September 2020
Primary completion	1 September 2021
Estimated completion	1 November 2021
Sites	1 location across Egypt

Drugs / interventions tested

platelet indices

Conditions studied

Abortion, Recurrent — all drugs for Abortion, Recurrent →

Sponsor

Menoufia University

Who can join

Adults 18 to 40, female only, with Abortion, Recurrent. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study was to evaluate relationship between platelet indices, red blood cell indices and recurrent pregnancy loss.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Menoufia University trials

Trials by the same sponsor.

NCT07522671 — Clinical Performance of 3D-Printed Resin and Zirconia Implant Restorations · NA · recruiting
NCT07516236 — Dynamic SvO2 in Predicting Fluid Responsiveness in Septic Shock · not yet recruiting
NCT07485517 — Deep Versus Moderate Neuromuscular Blocking · NA · recruiting
NCT07506044 — Dexmedetomidine as an Adjuvant During Dural Puncture Epidural · NA · recruiting
NCT07322471 — Efficacy and Safety of Flexible Ureteroscopy Versus Percutaneous Nephrolithotomy in Management of Staghorn Stones · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05190796 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Menoufia University
Last refreshed: 13 January 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05190796.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing